Literature DB >> 32098807

Modes of late mortality in patients with a Fontan circulation.

Chin Poh1,2, Tim Hornung3, David S Celermajer4, Dorothy J Radford5, Robert N Justo6, David Andrews7, Karin du Plessis8, Ajay J Iyengar9, David Winlaw10, Yves d'Udekem8,2,10.   

Abstract

OBJECTIVES: The mechanisms of attrition of the Fontan population have been poorly characterised and it is unclear whether some of the deaths are potentially preventable. We analysed the circumstances of late death in patients with a Fontan circulation, with a special focus on identifying lesions amenable to intervention that may have contributed to the decline of their circulation.
METHODS: Between 1975 and 2018, a total of 105 patients from a Bi-National Registry died beyond 1 year after Fontan completion, at a median age of 18.6 (IQR 13.8-26.0) years old, 12.7 (IQR 6.0-19.3) years after Fontan completion.
RESULTS: A total of 105 patients died-63 patients (60%) with an atriopulmonary (AP) Fontan, 21 patients (20%) with a lateral tunnel (LT) and 21 patients (20%) with an extracardiac conduit (ECC). 72 patients (69%) were reviewed within 2 years preceding death, with 32% (23/72) deemed to be clinically well. Fontan circulatory failure was the most common cause of death in 42 patients (45%). Other causes of death included sudden death/arrhythmia (19%), perioperative death (12%), neurological complication (7%) and thromboembolism (7%). All patients with an LT or ECC who died from Fontan failure had at least one surgical defect that was amenable to intervention at time of death.
CONCLUSIONS: Conventional clinical surveillance has been insensitive in detecting a significant proportion of patients at risk of late death. Fontan circulatory failure contributes to half of the late deaths. Patients with an LT or ECC Fontan who died with a clinical picture of circulation failure may have potentially correctable lesions. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Fontan physiology; heart failure; heart transplantation

Mesh:

Year:  2020        PMID: 32098807     DOI: 10.1136/heartjnl-2019-315862

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  3 in total

Review 1.  Narrative review of: risk stratification and implantable cardioverter-defibrillator therapy in adults with congenital heart disease.

Authors:  Julia Köbe; Kevin Willy; Lars Eckardt; Helmut Baumgartner; Kristina Wasmer
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

2.  A Multimodal Score Accurately Classifies Fontan Failure and Late Mortality in Adult Fontan Patients.

Authors:  Peter Kramer; Anastasia Schleiger; Marie Schafstedde; Friederike Danne; Johannes Nordmeyer; Felix Berger; Stanislav Ovroutski
Journal:  Front Cardiovasc Med       Date:  2022-03-10

3.  Pre- and Post-operative determinants of transplantation-free survival after Fontan. The Australia and New Zealand experience.

Authors:  Chin L Poh; Rachael L Cordina; Ajay J Iyengar; Diana Zannino; Leeanne E Grigg; Gavin R Wheaton; Andrew Bullock; Julian Ayer; Nelson Alphonso; Thomas L Gentles; David S Celermajer; Yves d'Udekem
Journal:  Int J Cardiol Heart Vasc       Date:  2021-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.